Day One Biopharmaceuticals Stock Market Value
| DAWN Stock | USD 11.16 0.34 2.96% |
| Symbol | Day |
Will Biotechnology sector continue expanding? Could Day diversify its offerings? Factors like these will boost the valuation of Day One. Projected growth potential of Day fundamentally drives upward valuation adjustments. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Day One data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share (1.52) | Revenue Per Share | Quarterly Revenue Growth (0.58) | Return On Assets | Return On Equity |
Investors evaluate Day One Biopharmaceu using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Day One's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. External factors like market trends, sector rotation, and investor psychology can cause Day One's market price to deviate significantly from intrinsic value.
It's important to distinguish between Day One's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Day One should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Conversely, Day One's market price signifies the transaction level at which participants voluntarily complete trades.
Day One 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Day One's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Day One.
| 11/07/2025 |
| 02/05/2026 |
If you would invest 0.00 in Day One on November 7, 2025 and sell it all today you would earn a total of 0.00 from holding Day One Biopharmaceuticals or generate 0.0% return on investment in Day One over 90 days. Day One is related to or competes with GeoVax Labs, BioLineRx, Tharimmune, Ainos, OSR Holdings, Lipocine, and Aditxt. Day One Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops and commercializes targeted thera... More
Day One Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Day One's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Day One Biopharmaceuticals upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 4.14 | |||
| Information Ratio | 0.1252 | |||
| Maximum Drawdown | 39.62 | |||
| Value At Risk | (6.53) | |||
| Potential Upside | 13.81 |
Day One Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Day One's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Day One's standard deviation. In reality, there are many statistical measures that can use Day One historical prices to predict the future Day One's volatility.| Risk Adjusted Performance | 0.1081 | |||
| Jensen Alpha | 0.8905 | |||
| Total Risk Alpha | 0.3983 | |||
| Sortino Ratio | 0.2036 | |||
| Treynor Ratio | 8.01 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Day One's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Day One February 5, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.1081 | |||
| Market Risk Adjusted Performance | 8.02 | |||
| Mean Deviation | 4.35 | |||
| Semi Deviation | 3.61 | |||
| Downside Deviation | 4.14 | |||
| Coefficient Of Variation | 741.59 | |||
| Standard Deviation | 6.72 | |||
| Variance | 45.2 | |||
| Information Ratio | 0.1252 | |||
| Jensen Alpha | 0.8905 | |||
| Total Risk Alpha | 0.3983 | |||
| Sortino Ratio | 0.2036 | |||
| Treynor Ratio | 8.01 | |||
| Maximum Drawdown | 39.62 | |||
| Value At Risk | (6.53) | |||
| Potential Upside | 13.81 | |||
| Downside Variance | 17.1 | |||
| Semi Variance | 13.03 | |||
| Expected Short fall | (6.16) | |||
| Skewness | 1.85 | |||
| Kurtosis | 5.37 |
Day One Biopharmaceu Backtested Returns
Day One appears to be slightly risky, given 3 months investment horizon. Day One Biopharmaceu secures Sharpe Ratio (or Efficiency) of 0.0655, which denotes the company had a 0.0655 % return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Day One Biopharmaceuticals, which you can use to evaluate the volatility of the firm. Please utilize Day One's Coefficient Of Variation of 741.59, downside deviation of 4.14, and Mean Deviation of 4.35 to check if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Day One holds a performance score of 5. The firm shows a Beta (market volatility) of 0.11, which means not very significant fluctuations relative to the market. As returns on the market increase, Day One's returns are expected to increase less than the market. However, during the bear market, the loss of holding Day One is expected to be smaller as well. Please check Day One's downside variance, as well as the relationship between the accumulation distribution and market facilitation index , to make a quick decision on whether Day One's price patterns will revert.
Auto-correlation | -0.32 |
Poor reverse predictability
Day One Biopharmaceuticals has poor reverse predictability. Overlapping area represents the amount of predictability between Day One time series from 7th of November 2025 to 22nd of December 2025 and 22nd of December 2025 to 5th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Day One Biopharmaceu price movement. The serial correlation of -0.32 indicates that nearly 32.0% of current Day One price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.32 | |
| Spearman Rank Test | -0.46 | |
| Residual Average | 0.0 | |
| Price Variance | 1.47 |
Pair Trading with Day One
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Day One position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Day One will appreciate offsetting losses from the drop in the long position's value.Moving together with Day Stock
Moving against Day Stock
| 0.81 | LYRA | Lyra Therapeutics | PairCorr |
| 0.74 | DWTX | Dogwood Therapeutics | PairCorr |
| 0.74 | ABP | Abpro Holdings | PairCorr |
| 0.69 | GNLX | Genelux Common | PairCorr |
| 0.66 | KURA | Kura Oncology | PairCorr |
The ability to find closely correlated positions to Day One could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Day One when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Day One - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Day One Biopharmaceuticals to buy it.
The correlation of Day One is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Day One moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Day One Biopharmaceu moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Day One can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Day One Correlation, Day One Volatility and Day One Performance module to complement your research on Day One. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Day One technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.